“…Yet, consistent with extant literature, classification accuracy was relatively low (i.e., AUCs all under 0.70), indicating MMPI-2-RF symptom validity scales should not be independently used to evaluate performance validity in neuropsychological evaluations. SVT elevations rates were also higher among those with invalid PVT performance, although a notable caveat is that MMPI-2-RF elevations are common even among validly performing patients, particularly for overreporting scales (Ingram et al, 2020). Part of this observed dissociation between SVTs and PVTs is that unlike PVTs, where a generally accepted threshold for invalidity has been established in the literature (i.e., ≥ 2 PVT fails; Larrabee, 2008;Rhoads et al, 2021), clearly delineated benchmarks have yet to be established for SVTs.…”